Clinical Trial Update: Feasibility and Safety of Immunoglobulin (Ig) Treatment in COPD Outpatients With Frequent Exacerbations: Pilot Study 1 [Phase 2]

View source ↗

Summary

Phase 2 pilot study assessing feasibility and safety of immunoglobulin treatment in outpatients with COPD and frequent exacerbations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Immunoglobulin treatment

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: COMPLETED